American Journal of Hematology
Fecha de publicación: 4 July 2019
Autores: Zimu Gong, Mina L. Xu, Mingyi Chen, Wei Cui, Hagop M. Kantarjian, Jorge E. Cortes, Ting Zhou, Guilin Tang, Wei Wang, L. Jeffrey Medeiros, Shimin Hu.
Background: Chronic myeloid leukemia (CML) is characterized by the presence of BCR‐ABL1, usually in the form of the Philadelphia chromosome (Ph) as a result of t(9;22)(q34;q11.2). Blast phase (BP), the terminal stage of CML, often has clinical and laboratory manifestations that mimic those of de novo acute leukemia.Leer más